Trials / Sponsors / Alkeus Pharmaceuticals, Inc.
Alkeus Pharmaceuticals, Inc.
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of ALK-001 on the Progression of Stargardt Disease Stargardt Disease | Phase 3 | 2026-04-01 |
| Active Not Recruiting | Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE) Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy | Phase 2 | 2019-12-20 |
| Completed | Phase 2/3 Study of ALK-001 in Geographic Atrophy Geographic Atrophy, Age Related Macular Degeneration, AMD | Phase 2 / Phase 3 | 2019-05-07 |
| Enrolling By Invitation | Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy | Phase 2 | 2015-08-01 |
| Completed | Phase 1 Safety Study of ALK-001 in Healthy Volunteers Stargardt Disease, Age-related Macular Degeneration, Other Retinal Dystrophies | Phase 1 | 2014-04-01 |